← All organizations

Mabwell

For profit

Also known as: Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 30, 2025

Timeline

2010s

Jun 1, 2017
Mabwell— Founded

Drugs by trial phase (24 distinct, 45 trials)

Phase 3 (11 own, 0 via acquisition)

Phase 2 (9 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

mwav201

Recent trials (47)

NCT07216560Lead sponsorPhase 1/Phase 2Nov 30, 2025
NCT07265622Lead sponsorPhase 1/Phase 2Nov 12, 2025
NCT06908928Lead sponsorPhase 1Aug 11, 2025
NCT07292714Lead sponsorPhase 2Jul 15, 2025
NCT06947226Lead sponsorPhase 1/Phase 2Apr 30, 2025
NCT06926998Lead sponsorPhase 1/Phase 2Apr 15, 2025
NCT06823427Lead sponsorPhase 2Jan 17, 2025
NCT06772766Lead sponsorPhase 1Dec 30, 2024
NCT06804590Lead sponsorPhase 3Nov 16, 2024
NCT06663878CollaboratorN/AOct 31, 2024
NCT06692166Lead sponsorPhase 3Sep 10, 2024
NCT06592326Lead sponsorPhase 3Aug 22, 2024
NCT06492005Lead sponsorPhase 2Jul 31, 2024
NCT06752746Lead sponsorPhase 1Mar 21, 2024
NCT06196736Lead sponsorPhase 3Dec 29, 2023

Details

Founded: Shanghai, CN Jun 1, 2017
Last known activity: Nov 30, 2025